Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of Korean Medical Science ; : 1576-1581, 2011.
Article Dans Anglais | WPRIM | ID: wpr-227747

Résumé

Under conditions of Na+ channel hyperactivation with aconitine, the changes in action potential duration (APD) and the restitution characteristics have not been well defined in the context of aconitine-induced arrhythmogenesis. Optical mapping of voltage using RH237 was performed with eight extracted rabbit hearts that were perfused using the Langendorff system. The characteristics of APD restitution were assessed using the steady-state pacing protocol at baseline and 0.1 microM aconitine concentration. In addition, pseudo-ECG was analyzed at baseline, and with 0.1 and 1.0 microM of aconitine infusion respectively. Triggered activity was not shown in dose of 0.1 microM aconitine but overtly presented in 1.0 microM of aconitine. The slopes of the dynamic APD restitution curves were significantly steeper with 0.1 microM of aconitine than at baseline. With aconitine administration, the cycle length of initiation of APD alternans was significantly longer than at baseline (287.5 +/- 9.6 vs 247.5 +/- 15.0 msec, P = 0.016). The functional reentry following regional conduction block appears with the progression of APD alternans. Ventricular fibrillation is induced reproducibly at pacing cycle length showing a 2:1 conduction block. Low-dose aconitine produces arrhythmogenesis at an increasing restitution slope with APD alternans as well as regional conduction block that proceeds to functional reentry.


Sujets)
Animaux , Lapins , Aconitine/pharmacologie , Potentiels d'action/effets des médicaments et des substances chimiques , Troubles du rythme cardiaque/induit chimiquement , Entraînement électrosystolique , Électrocardiographie , Coeur/physiopathologie , Système de conduction du coeur/physiologie , Myocarde/anatomopathologie , Canaux sodiques/effets des médicaments et des substances chimiques , Fibrillation ventriculaire/physiopathologie
SÉLECTION CITATIONS
Détails de la recherche